Hearing Loss Trial, Recruiting (NCT07416292)

Hearing Loss Trial, Recruiting NCT07416292 Sponsor: Heikki Löppönen Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT07416292 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Group 1:

You have hearing loss in both ears, ranging from mild to complete (total) hearing loss

Group 2:

Your hearing is within the normal range (confirmed by a standard hearing test result below 20dB)
Your cognitive (thinking), language, and reading/writing development is considered typical for your age

Who may not be able to join:

Both Group 1 and Group 2:

You have a heart condition
You have a developmental disorder affecting the brain
You have a chromosomal condition (a difference in your genetic makeup) (confirm with trial site)
You have a severe structural problem with the inner ear
You have significant difficulties with both hearing and vision at the same time

Group 2 only:

There are concerns about your attention, behaviour, or emotional wellbeing

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +358405656183

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07416292

Sponsor: Heikki Löppönen

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: +358405656183

More information: https://clinicaltrials.gov/study/NCT07416292

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Group 1:

You have hearing loss in both ears, ranging from mild to complete (total) hearing loss

Group 2:

Your hearing is within the normal range (confirmed by a standard hearing test result below 20dB)
Your cognitive (thinking), language, and reading/writing development is considered typical for your age

Who may not be able to join:

Both Group 1 and Group 2:

You have a heart condition
You have a developmental disorder affecting the brain
You have a chromosomal condition (a difference in your genetic makeup) (confirm with trial site)
You have a severe structural problem with the inner ear
You have significant difficulties with both hearing and vision at the same time

Group 2 only:

There are concerns about your attention, behaviour, or emotional wellbeing

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Heikki Löppönen

Registry

ClinicalTrials.gov

Start date

1 March 2026

Est. completion

31 December 2029

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Clinical Evaluation of Language Fundamentals (CELF5)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov